key: cord-0429058-3kr9me2e
authors: Tebit, Denis M.; Nickel, Gabrielle; Gibson, Richard; Carpenter, Crystal; Rodriguez, Myriam; Hathaway, Nicolas J.; Bain, Katie; Reyes-Rodriguez, Angel L.; Bonogo, Jennifer; Canaday, David; McDonald, David; Bailey, Jeffrey A.; Arts, Eric J.
title: Elucidating the viral and host factors enabling the cross-species transmission of primate lentiviruses from simians to humans
date: 2020-10-13
journal: bioRxiv
DOI: 10.1101/2020.10.13.337303
sha: e8810ad92acb49f87a488ce6d30ad79012a3fd4c
doc_id: 429058
cord_uid: 3kr9me2e

The HIV-1 epidemic originated from a cross-species transmission of a primate lentivirus from chimpanzees to humans near the turn of the 18th century. Simian immunodeficiency viruses have been jumping between old world monkeys in West/Central Africa for thousands of years. So why did HIV-1 only emerge in the past century? This study examined the replicative fitness, transmission, restriction, and cytopathogenicity of 26 primate lentiviruses. Pairwise competitions of these primate lentiviruses revealed that SIVcpz had the highest replicative fitness in human or chimpanzee peripheral blood mononuclear cells, even higher fitness than HIV-1 group M strains responsible for 37 million infections worldwide. In contrast the “HIV-2 lineage” (SIVsmm, SIVmac, SIVagm, and HIV-2) had the lowest replicative fitness. SIVcpz strains were less inhibited by human restriction factors than the “HIV-2 lineage” strains, a restriction that was inversely correlated with replicative fitness. SIVcpz from the chimpanzee subspecies Pan troglodytes troglodytes (Ptt) was slightly more fit in human cells than the strains from Pt schweinfurthii (Pts). However, unlike all other primate lentiviruses (including the HIV-2 lineage), SIVcpz was nonpathogenic in human tonsillar tissue and did not deplete CD4+ T-cells, consistent with the slow or nonpathogenic disease observed in chimpanzees. Despite the close phylogenetic relationship between SIVcpz_Ptt and HIV-1, this epidemic was either caused by cross species transmission of a rare, undiscovered SIVcpz strain of higher virulence or higher virulence differentially evolved among HIV-1 subtypes during the human epidemic. Author summary Invasion of wild animal habitats by humans can have devastating consequences for the human population as evident by the HIV-1 and SARS-CoV-2 epidemics. With SARS-CoV-2, a recent zoonotic jump, likely from bats, will help to identify a coronavirus progenitor. In contrast, simian immunodeficiency virus (SIV) jumped into humans over 100 years ago from a possibly extinct sub-species of chimpanzees and/or extinct lineage of SIV. We examined replicative fitness and pathogenesis of 26 different primate lentiviruses in human and chimpanzee primary lymphoid cells from blood and within tonsils. SIV from a specific chimpanzee species and lowland gorillas were the most capable of infecting and replicating in human and chimp lymphoid cells but they did not result in the pathogenesis related to disease in humans. In contrast, SIV from other old world monkeys were pathogenic but could not replicate efficiently in human cells. We propose the main HIV-1 is derived from a distinct jump of a very rare SIV strain in chimps leading to AIDS pandemic.

Invasion of wild animal habitats by humans can have devastating consequences for the human population as evident by the HIV-1 and SARS-CoV-2 epidemics. With SARS-CoV-2, a recent zoonotic jump, likely from bats, will help to identify a coronavirus progenitor. In contrast, simian immunodeficiency virus (SIV) jumped into humans over 100 years ago from a possibly extinct sub-species of chimpanzees and/or extinct lineage of SIV. We examined replicative fitness and pathogenesis of 26 different primate lentiviruses in human and chimpanzee primary lymphoid cells from blood and within tonsils. SIV from a specific chimpanzee species and lowland gorillas were the most capable of infecting and replicating in human and chimp lymphoid cells but they did not result in the pathogenesis related to disease in humans. In contrast, SIV from other old world monkeys were pathogenic but could not replicate efficiently in human cells. We propose the main HIV-1 is derived from a distinct jump of a very rare SIV strain in chimps leading to AIDS pandemic.

Simian immunodeficiency viruses (SIV) are a collection of primate lentiviruses differing as much as 50% (in nucleotide diversity) and infecting a genetically diverse population of old world monkeys (1, 2) . In contrast the distinction between "human" immunodeficiency virus type 1 (HIV-1) and "simian"IV from chimpanzees (cpz) are more in the assigned name considering SIVcpz and HIV-1 share more homology than SIVs that infected different old world monkeys (1) (2) (3) (4) .

Zoonotic transmissions of SIV occurred through several independent jumps from chimpanzees to humans leading to the establishment of 4 groups within HIV-1 (M, N, O and P) and from sooty mangabeys to humans for the 9 groups (A-I) within HIV-2(1-7). HIV-1 group M is the most prevalent human lentivirus accounting for >95% of the 36 million infections in humans while HIV-2 and HIV-1 group O are responsible for 1-2 million and <30,000 infections, respectively (2, 8) . The rare HIV-1 groups N and P are found in less than a hundred individuals residing in or visiting Equatorial rainforest of West and Central Africa (2, (9) (10) (11) (12) (13) , also the origin of HIV-1 group M zoonotic jump. West Central African countries with Cameroon at its epicenter, represent the oldest epidemic illustrated by high HIV genetic variability in the current infected population (2, 13) .

There are more than 40 different SIV lineages infecting more than 45 species of African non-human primates, most commonly chimpanzees, gorillas and other old world monkeys (3) (4) (5) (14) (15) (16) . As an example, SIVsmm infects sooty mangabeys (smm) (or Cercocebus atys) in West Africa and is the likely source of HIV-2 (17) (18) (19) . SIVcpz infects the Pan troglodytes troglodytes (Ptt) and Pan troglodytes schweinfurthii (Pts) sub-species of chimpanzees common in central and west central Africa (7, (20) (21) (22) . While SIVcpz from Ptt is the origin of HIV-1 groups M and N, Pts related SIV lineages have not been found in humans (7, 22, 23) . Likewise, SIVcpz has not jumped to other subspecies of chimpanzees (i.e. Pt verus or vellerosus or bonomos) which raises the possibility of incompatibility or lack of opportunity for this cross-species transmission(24-27). It is still unclear if SIV infecting lowland gorillas (Gorilla gorilla or gor) inhabiting the Equatorial forest of Central Africa (15, 16) were the direct link for the primate lentiviral jump to humans to establish HIV-1 groups O and P or if this jump involved chimpanzees as an intermediate host.

A cross-species lentiviral inoculation establishing a new, successful zoonosis may be governed by higher replicative capacity (2, 28) and reduced sensitivity to innate restriction factors in the new primate host (22, 29) . As an example, increased sensitivity to human restriction factors or low replicative fitness of SIVcpz from Pts chimpanzees in susceptible human CD4+ cells may have prevented this cross species transmission. Alternatively, humans were never exposed to an SIV from infected Pts chimpanzees. Given the deforestation and exploitation in sub-Saharan Africa after the turn of the 18 th century, a time which coincided with the introduction then rapid expansions of the HIV-1 and -2 epidemics, it is unlikely but not impossible that humans were only exposed to SIV from Ptt and not Pts chimpanzees. Primate lentiviruses have been jumping and circulating through old world primate populations, including humans, for thousands of years(30).

Cross-specific transmission and variable host adaptions likely resulted in extinction of many primate lentiviral lineages, attenuations, and even the birth of novel lineages through recombination events that occur during super-infections with SIVs of different primates(31-34).

In fact, SIVcpz are recombinants between two lentiviruses originating from the red capped mangabey and greater spot-nosed monkey or a closely related species (35) .

Following the zoonotic transmission to humans around the 1920s, HIV-1 group M rapidly evolved into 10 different subtypes within the Congo Basin but with increased human migration and trade with sub-Saharan Africa, many HIV-1 subtypes founded new epidemics across the globe and even recombined to generate new circulating recombinant forms (CRFs) (2) (1, 36) . This collection of group M subtypes have evolved almost equidistant from the root of the HIV tree but despite the similar evolutionary rates, considerable differences in virulence and transmission efficiency may still be shaping subtype spread (37) (38) (39) . In particular, HIV-1 subtype D may be the most virulent in humans (37, 40, 41) but has decreased in prevalence in the past 30 years whereas the rapid expansion and predominance of HIV-1 subtype C worldwide may be related to its lower virulence and average transmissibility (2) . Following thousands of pairwise competitions of HIV-1 in human peripheral blood mononuclear cells (PBMCs), primary T cells, macrophages, tonsillar tissue, and DC-T cell cocultures, we have established a rank order in replicative or "pathogenic" fitness: HIV-1 groupM/subtype F ≥ B = D = CRF12,17_BF > A = CRF02_AG = CRF01_AE > C > HIV-1 grpO > HIV-2 (38, 42, 43) . Although HIV-1 replicative fitness in primary T cells and macrophages is a strong correlate of disease progression in humans (37, 44, 45) , this relationship is not absolute especially with HIV-2 in humans and some SIV strains in African green monkeys (agm) and chimpanzees (46) (47) (48) (49) (50) (51) (52) . A better surrogate of virulence may be direct infection of primary lymphoid organs like tonsillar tissue in which viral pathogenicity, T-cell depletion, and viral propagation rates can be measured (53, 54) .

In the present study, we utilized various primary human cell types to determine the ex vivo fitness and pathogenicity of a diverse set of 21 primate lentiviral isolates that included HIV-1 groups M, N, O, HIV-2, and SIVs of cpz, gor, mac, smm, and agm. We have performed over 300 pairwise dual infections using the 21 primate lentivirus isolates in peripheral blood mononuclear cells from both human and chimp (Pan troglodytes verus; Ptv) donors, along with monoinfection of PMBCs and cell lines, and finally dendritic cell-mediated transinfections of human (Homo sapiens; Hs) PBMCs. We determine the relative repression of primate lentivirus replication in human cells by various restriction factors and correlated this to replicative fitness. Finally, we accessed the cytopathogenicity on CD4+ T cells in human tonsillar explant tissue following infection with the HIV-1, HIV-2 and SIV isolates. Our results show that SIV strains from chimps and gorillas had similar ex vivo fitness as HIV-1 group M strains in both human and chimp PBMCs, while HIV-1 group O, SIVmac/smm, and HIV-2 isolates had sequentially lower fitness. Based on the higher relative fitness and reduced restriction on SIVcpz-Ptt in human T-cells compared to that of SIVcpz-Pts or any other SIV strain, we provide experimental evidence that SIVcpz from 7 Ptt was most adapt in establishing infection in humans. However, this initial zoonotic transmission to humans was likely non-pathogenic based on tonsillar tissue studies.

Twenty-six HIV and SIV strains representing 10 HIV-1 group M, 3 group O, 1 group N, 6 SIVcpz, 1 SIVgor, 2 HIV-2 and 1 each of SIVsmm, SIVmac and SIVagm ( Figure 1A and B) were propagated on either U87.CD4.CCR5 cell line or human PBMC. Infectious titer was determined in human PBMCs using a standard TCID50 assay ( Figure 1B ). All isolates were R5 as confirmed by their replication on U87.CD4.CCR5 but not U87CXCR4 cell lines. Genotypes were confirmed through Sanger sequencing and phylogenetic analyses of gag and env; neighbor-joining trees shown in Figure 1A and Supplementary Figure 1 . The group M strains clustered more closely with SIVcpz MB897 (Fig 1A) while SIVgor_CP684 grouped with the group O strains, as previously described (Fig 1A and B) . SIVcpz EK505 is more closely related to the HIV-1 group N strain, YBF30. The HIV-2 strains VI1835 and VI1905 (both subtype A) clustered with SIVsmm, the source of HIV-2 ( Fig 1A; Supplementary Figure 1 ).

The replication kinetics of all the primate lentiviruses were determined on human PBMCs and the brain glioma cell line U87 expressing huCD4 and either from human (Hs for Homo sapiens) CCR5 or rhesus macaque (Mm for Macaca mulatta) CCR5. All cell types were infected with the same MOI and monitored for virus production (and cell viability, see below) for 12 days to determine the amount of reverse transcriptase (Methods). Virus replication kinetics over a course of a 12 day infection in PHA/IL2-treated human PBMCs (as measured by area under the RT activity curve) were not significantly different between the HIV-1 group M, O and SIVcpz strains (Fig 2A) . In the human brain glioma cell line expressing HsCD4 with HsCCR5 or MmCCR5, the HIV-1 group M strains had 10-fold and nearly 100-fold greater replication kinetics than HIV-1 group O and SIVcpz strains, respectively ( Figure 2A ). When comparing growth kinetics for specific primate lentivirus strains, the HIV-1 group M subtype A strain, A74 (Fig 2Bi) replicates more efficiently in the U87 cell lines than in human PBMCs whereas the human lentiviruses, HIV-1 group O CM02-41 (Fig 2Bii) and HIV-2 VI1835 isolates (Fig 2Biii) replicate to similar levels in PBMCs and the U87 cell lines (with Hs or MmCCR5). However, the SIV strains of chimpanzees (cpz) (Supplemental figure 2) and of African green monkeys (agm) (Fig 2Biv) replicated at higher levels in HsPBMCs than in U87 cells. We propose that the HIV-1 group M is more adapt to replication in many human cell types aside from just CD4+ T-lymphocytes as compared to HIV-1 group O and HIV-2.

Within a human host, activated CD4+ T-cells in the gut, lymph nodes, and other tissues may be responsible for the majority of HIV-1 replication. T-cell activation and delivery of the HIV may be mediated by direct dendritic cell contact. The replication of primate lentiviruses in PBMCs mediated by human MDDC trans-infection was significantly greater (2-to 3-fold) than that observed in direct lentivirus exposure of PHA/IL-2 treated PBMCs of the same donor ( Supplementary Fig.2 ). The highest fold change (ca. 3-fold) in replication mediated by DCs was observed with the HIV-1 group M A74 virus (Supplementary Figure 2B) . In using the MDDC and PBMCs of a different donor, we observed a similar level of enhancement of lentiviral replication with MDDC-mediated trans infection.

Due to the inherent variation of culture conditions, logarithmic growth of viruses, and variability in viral monitoring assays, only gross differences in replication kinetic of different lentiviruses can be measured in monoinfection (45, 55, 56) . Direct dual virus competitions at low multiplicity of infection in the same contained culture provides a relative, reproducible measure of replicative fitness with minimal variance (42, 44, 45, 55, 57) . Thus, we performed pairwise competitions with 21 lentiviruses in both human and chimpanzee PBMCs using viruses (schematically illustrated in Figure 3A ). A total of 253 separate pairwise competitions in HsPBMC at an MOI of 0.005 were harvested after 12 days post infection, i.e. peak virus production. Dual infections at this MOI and in this time frame limits recombination to <0.1% of the observed dual virus replication (44, 58, 59) . We obtained a limited supply of blood/PBMCs from P.t. verus (Ptv) to perform 82 pairwise competitions involving inter-lentiviral pairs (e.g. HIV-1 M strain versus SIVcpz rather than HIV-1 M subtype A versus HIV-1 M subtype B). Ptv was selected for PBMCs since this chimpanzee subspecies lacked infection by SIVcpz (as tested to date)(24-27). For intergroup/type competitions performed in both Hs and PtvPBMCs, the extracted DNA was PCR amplified in a gag coding region, that is conserved among primate lentiviruses. Extracted DNA from intra HIV-1 group M competitions were amplified using the envelope primers described previously (42, 44, 55, 57, 60, 61) ( Figure 3A ). PCR products were barcoded and sequenced by next generation deep sequencing. We then processed resulting reads through the SeekDeep pipeline which performs de novo clustering at a single base resolution (62) . SeekDeep is advantageous as resulting measures are centered around the most abundant viral clones in the quasispecies/swarm and thereby avoid biases that may be engendered by direct mapping to a singular strain reference sequence. We were unable to propagate sufficient HIV-1 P RBF168 for this study but the SIVgor CP684 was over 90% identical in Gag, Pol and Env sequence to groups O and P(16), very similar to the homology between HIV-1 groups M and N and their respective SIVcpz progenitor.

In the competitions involving SIVcpz and HIV-1 group M in HsPBMCs ( Figure 4A and C), and the reciprocal plot in Figure 4B and D in PtvPBMCs, SIVcpz strains trended to slightly higher replicative fitness than HIV-1 group M isolates. Again, the other SIV strains (not infecting chimpanzees) or the HIV-2 strains (originating from SIVsmm) were less fit than SIVcpz or group 

Host factors such as Trim5a, APOBEC 3F/G/H, tetherin/BST2, and SamHD1 have all been shown to restrict xenotropic retrovirus replication and most have been associated with preventing cross species transmission of primate lentiviruses(29,64). We explored the ability of these restriction factors in human cells to reduce replication kinetics of NHP lentiviruses as one mechanism to prevent a jump into humans. For these studies, we utilized the cell line group M or SIVcpz isolate as described in Figure 3 . The average intragroup/type fitness values of each of the 21 lentiviruses were then compared to the relative restriction by human Trim 5α (i), Tetherin (ii), APOBEC 3F (iii), and 3G (iv) and we observed no significant correlations ( Figure   7A ). However, when the average fitness of only SIVs were plotted, a significant inverse correlation was observed between replicative fitness and release of restriction by Trim 5α, Tetherin, or the additive effects by all four factors (Figure 7Bi , ii, and v). Again, the SIVcpz strains (especially cpz_Ptt) had the highest replicative fitness and appeared to be the least restricted in human cells.

Unlike PBMCs, human tonsils are permissive cells that do not require stimulation with mitogens or IL-2 for HIV propagation (65) . To determine the cytopathic effect and CD4 T-cell depletion rate by these primate lentiviruses, human tonsils were infected with the same infectious titers and monitored for virus production and CD4 T-cell depletion based on pyroptosis and/or necrosis relative to uninfected controls (53, 54) . It is important to note that depletion of CD4 T-cell in human tonsils by R5-using HIV-1 subtype B strains (average of 10% herein with the HIV-1 group M isolates) is lower than reported with X4-using HIV-1 strains, typically reaching a 65% loss in tonsillar CD4+ T cells (54) . In this study, the highest CD4+ T cell depletion was observed with SIVmac (average 27%), followed by A74 (18%), VI1835 (16%) and D107 (12%) ( Figure 8A ).

Despite the relatively low replication in CD4+ T-cells, HIV-2 and SIVmac/agm still depleted significant levels of CD4 T-cells in human tonsils ( Figure 8B ). Exposure to the human tonsillar tissue to SIVcpz strains (Ptt and Pts) resulted in minimal CD4+ T cell depletion (1 to 3.5%; Figure   8A ) despite high levels of replication in these tissues ( Figure 8B ). SIVcpz_Pts Nico had the highest ratio of virus production versus CD4+ T-cell depletion in the tonsillar tissues. All the primate lentiviruses within HIV-1 groups (M, N, O), HIV-2, SIVgor and SIVagm/mac were significantly better at depleting CD4 T-cells than SIVcpz (except group N and SIVgor, limited data points). In contrast, there was no difference in the levels of CD4 T-cell depletion in the tonsillar tissues between any of the types/groups when SIVcpz was not included in the ANOVA analyses.

No correlation was observed between the relative replication in the tonsillar tissue and the level of CD4 depletion by these viruses. SIVcpz had the highest replicative fitness in human PBMCs and in the tonsillar tissues. In contrast, SIVcpz infection was associated with minimal cytopathogenicity in human tonsillar tissue resulting in the greatest ratio of virus production to CD4+ T cell death of any primate lentivirus ( Figure 8C ). In contrast, the HIV-2 isolates, SIVagm, and SIVmac showed an average depletion of CD4+ T cells, i.e. comparable to that observed with HIV-1 group M, O, and all other primate lentiviruses (except SIVcpz) ( Figure 8A and B). Based on the poor virus production in human tonsillar tissue (as well as average fitness in HsPBMCs), the ratio of replication to CD4 T cell depletion of HIV-2 and SIVagm/mac was the lowest for all primate lentiviruses ( Figure 8C ). As described below, these findings might suggest that pathogenicity/virulence could have evolved as a trait in humans following a zoonotic jump.

Phylogenetic studies have revealed a complex history of interspecies jumps of lentiviruses among catarrhine monkeys or "old world" monkeys. Based on the discovery of an endogenous primate lentivirus in lemurs of Madagascar, best estimates place the introduction of lentivirus into monkeys approximately 17 million years ago from a jump of a primordial lentivirus which then branched into FIV and SIV (66) . Despite evidence of primate lentiviruses in old world monkeys for millions of years, our knowledge of this evolution is largely based on the jumps during the past 10,000 years resulting in the existing lentiviral lineages in primates, many of which are unstable in their current host species. An example of this instability is the jump of SIV from sooty managabeys into humans in 1930s (67) which resulted in HIV-2 with a peak epidemic of 1-2 million, limited transmission success, and the progressive loss in prevalence within humans, even before the introduction of antiretroviral treatment. HIV-1 group O, N, and P had even less success surviving in humans following introductions from the gorilla and/or chimpanzees; jumps dated to sometime in the 1920s for group O and 1960s for N (22, 67, 68) . In contrast, HIV-1 group M emerged in humans with a jump from chimpanzees (Ptt) in the Congo basin after the turn of the 19 th century, an event that has now resulted in over 40 million deaths with another 37 million infected humans (67) (68) (69) . There is no clear evidence of attenuation of HIV-1 virulence or reduction in transmission efficiency but some in vitro studies suggest this possibility (39, 70) .

This study was designed to compare the competitive replicative fitness and virulence of different lentiviral strains isolated from various primate species. Exposure of a primate to a xenotropic lentivirus is unlikely to result in a cross-species transmission event due in part to protective barriers, e.g. innate defenses and various restrictions factors. Nonetheless these restriction factor/innate defenses appear to show variable protection against different, foreign lentiviruses. To understand the overall restriction of primate lentiviruses in primary human cells susceptible to HIV, we compared the replicative fitness of primate lentiviruses in both human and chimpanzee PBMCs by performing over 250 with 21 lentiviral isolates of HIV-1 groups M, N, O, HIV-2, SIVcpz, gor, smm, and agm. To determine relative virulence upon a possible jump to humans, we compared the relative replicative fitness of these primate lentiviruses to the inhibition by various human restriction factors and the relative depletion of CD4+ T cells in human tonsillar tissue.

To summarize, SIV strains from Ptt and Gor and HIV-1 group N appeared slightly more fit than even HIV-1 group M replicating in both human and chimp PBMCs. However, as previously published, there was a wide range in replicative fitness among HIV-1 group M subtypes with subtype A and C strains again being consistently less fit (37, 42, 55, 57) . When these HIV-1 group M strains of lower fitness were removed from the analyses, there was no significant difference in the replicative fitness of SIV from chimpanzees and gorillas and the HIV-1 group M and group N isolates found in humans. SIVcpz or SIVgor (progenitor of HIV-1 group P) are significantly more fit than HIV-1 group O in human PBMCs. Finally, SIV from African green monkeys and Sooty mangabey had the lowest replicative fitness in both human and chimp PBMCs, similar to the low replicative fitness observed with HIV-2. We determined that the relative level of replication of these non-human primate lentiviruses in human and chimp PBMCs reflect the cumulative inhibition by the various human restriction factors, with tetherin/BST2 being the most restrictive.

Based on the cumulative data presented herein, it is clear that SIVcpz and SIVgor have the greatest ability to replicate in human PBMCs. However, the SIVcpz derived from Pts, which did not establish lentivirus epidemic in humans, was less fit in human PBMCs than SIVcpz of Ptt.

SIVcpz from Pts or Ptt were also inhibited the least by human restriction factors. Based on the similar overlap and invasion of humans into the Pts and Ptt habitats in the Rift Valley of East Africa, Congo Basin of Central Africa, and the tropical south of West Africa, it is unlikely that humans would be exposed less to Pts than to Ptt chimpanzees. Findings presented herein suggest that the SIVcpz of Ptt compared to SIVcpz of Pts was more compatible for cross species transmission to humans and gained the foothold necessary for transmission and human adaptation.

The ability of a lentivirus to replicate in the primary susceptible cells in a host does not always correlate with pathogenesis. A strong example is the lack of disease in African Green Monkeys despite the high viral loads of SIVagm produced by an abundance of infected T-cells in these animals (46, 47) . There has only been one study that has characterized disease progression of a chimpanzees infected by SIVcpz (a Pts strain) in the wild but raised in captivity. With this animal there was little evidence of disease despite an increasing viral load during the length of infection (48) . In humans, several studies have described a direct correlation between the rate of disease progression and the replicative fitness of the infecting HIV-1 isolates in primary Tcells (37, 44, 45, 71) . This is best illustrated by the low replicative fitness of HIV-1 isolates derived from patients with slow or non-progressing disease versus the high replicative HIV fitness among rapid progressors. In this study, we compared the cytopathogenicity of these primate lentiviruses in primary human lymphoid tissue, i.e. resected tonsillar tissue. There was a clear disconnect between the ability of non-human primate lentiviruses to propagate in human tonsillar tissue and the pyroptosis/cell death of the CD4+ T cells within the same tissue. Similar levels of T-cell death was mediated by HIV-2, SIVagm, and SIVsmm with low replicative fitness than by HIV-1 group M/N and SIVgor with high replicative fitness. In contrast, SIVcpz having the highest replicative fitness in tonsillar tissue (as well as in human and chimp PBMCs) was associated with minimal pyroptosis and all manner of T-cell death in this tonsillar tissue. The inability of SIVcpz to mediate cytopathogenicity in human T-cells may correspond to the minimal pathogenesis or lack of disease described in most SIV infected chimpanzees (48, 49) . Again, in contrast to the most fit using an RT assay as described previously (72).

MDDCs were isolated as described previously (73) . Briefly, CD14 + beads (Miltenyi Biotech) were used to isolate CD14 + monocytes from healthy donor human PBMCs. These were then cultured in the typical 10% FBS/RPMI media and supplemented with 10ng/ml IL-4 and 50ng/ml GM-CSF (Miltenyi Biotech). MDDCs were matured by overnight stimulation with 100ng/ml LPS (Sigma) 5-6 days after initiation of the cultures. Mature MDDCs were pelleted, washed and resuspended in fresh medium ready for co-culture with PBMCs and infection with viruses.

Twenty six primate lentiviruses, primary isolates or molecular clones were used for this study and included HIV-1 group M (n=10), N (n=1) and O (n=3), and HIV-2 (n=2) and from nonhuman primates; SIVcpz (n=6), SIVgor (n=1), SIVagm (n=1), smm (n=1), and mac (n=1). A full list of the viruses, their origins, phylogenetic relations in env and gag, titers are outlined in Figure   1A The SIVcpz strains Nico and Noah were obtained from a chimpanzee infected in the wild, maintained in captivity, and whose virus was then used to infect another chimpanzee (48) .

Plasmids of the proviral clones (CMO2.4, CP684, EK505, Gab1-1, MB897-1) were used to generate infectious virus by transfecting 293T cells using the Effectene transfection reagent (QIAGEN, Valencia, CA). Supernatant containing virus was collected 2 days post transfection, clarified by centrifugation at 2,500 rpm for 10 mins and purified through a 0.45um pore-size filter (Millipore, Billerica, MA). Transfection derived supernatants were subsequently briefly passaged in either human PBMC while all other primary isolates were briefly passaged in PBMCs to generate virus stocks. The tissue culture infectious dose for 50% infectivity (TCID50 expressed as IU/ml)) of propagated viruses was calculated by the Reed and Muench method as described previously (42) . Virus productions in supernatant was determined by a positive RT activity (two standard deviations above the negative control). RT activity is the preferred assay considering the enzyme is present in all HIV or SIV strains. Supernatants from each tonsil infection was also assayed for RT activity (72) .

Ex vivo pathogenic fitness for the isolates was determined by infecting human and chimpanzee PBMCs using methods described previously (42, 44, 55, 57, 60, 61) . In human PBMC, pathogenic fitness of HIV/SIV isolates was performed by full pair wise competition using 9 group for both viruses, i.e. 1000 IUs. Virus production was monitored by measuring the RT activity until peak production at day 12 when cells were harvested and stored at -80 o C.

Due to the closer genetic relationship between HIV-1 group M, DNA extracted from intra-HIV-1 group M competitions were PCR amplified using envelope primers described previously (42, 44, 55, 57, 60, 61) . Briefly, C2-C3 region of envelope was amplified by PCR using the primers E80 and E125 primers (44) . For the DNA extracts of the competitions using the more It is important to stress that the same results (+/-2% variance) was observed with both NGS platforms despite the increased error rates with 454. The alignments and analysis pipeline described below "count" the number of reads that cluster with one versus the other lentiviruses in 25 the competition. All quasispecies of lentiviruses are genetically distinct using this amplified and sequenced gag or env region.

Sequence data was extracted and analyzed using SeekDeep, a software suit that enables de novo clustering thereby avoiding potential artifacts that may occur due to alignment directly to reference sequences in situations of divergent sequence populations. It provides start-to-finish workflow from raw sequences files to population-level clustering, tabular and graphical summaries (62) . The program has three components namely: extractor, qluster and process Clusters.

Sequence reads were first separated at the sample level based on their MIDs/bar codes followed by the detection and removal of forward and reverse PCR primers to leave the targeted region. Additional filtering was performed to ensure expected target length and to remove low quality reads as indicated by low quality or ambiguous (N) bases in the sequences. Next, was the clustering phase which involved the collapsing of unique reads except for high quality differences. Clusters that were up to 2 bases different from a more abundant haplotype were collapsed. Clusters composed of a single read were removed. During the SeekDeep process clustering phase, a final filtering was performed to remove low abundance artifacts and chimeric haplotypes, determined as a haplotype that was a combination of two other more abundant haplotype clusters (>2-fold relative to potential chimera), low frequency chimeric haplotypes that represented combinations of and low abundance artifacts. These final haplotype clusters were than mapped to known input strain sequences allowing up to 5 mismatches and renamed appropriately. The relative abundance of the strains in each competition was then calculated and interactive graphs of the results were created to assess quality and view the data (62) . Endogenous expression of these restriction factors is rarely detected by Western blots using antibodies. The reduction of the restriction factor mRNA levels with these optimized siRNA was between 65-95%. Please note the same U87 cell culture treated with one specific siRNA was split and utilized for infections with all lentiviruses.

We employed the spearman correlation to determine if there was any relationship between the genetic distance and the fitness in human PBMC, as well as fitness and CD4 + T-cell depletion in the tonsil by the isolates. 

Supplementary Figure 4 . Primate lentivirus replication in human CD4+ U87 cells expressing HsCCR5 and pre-treated with siRNA to human restiriction factors Trim 5a (A), Tetherin/BST2 (B), APOBEC3F (C), and APOBEC3G (D). Replication is plotted as the fold change in increased lentivirus replication on days 3, 5, and 7 in the presence of siRNA to specific human restriction factors. 

The origin and diversity of the HIV-1 pandemic

Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease

AIDS as a zoonosis: Scientific and public health implications

Origin and diversity of human retroviruses

Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1

Human immunodeficiency viruses: SIV infection in wild gorillas

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. NatMed

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

Widely varying SIV prevalence rates in naturally infected primate species from Cameroon

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon

Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses

Human immunodeficiency viruses: SIV infection in wild gorillas

Origin of the HIV-1 group O epidemic in western lowland gorillas

Human Immunodeficiency Virus Type 2 Infection Associated with AIDS in West Africa

An African primate lentivirus (SIVsmm) closely related to HIV-2

Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Tai Forest, Cote d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2

JUNP on H (UNAIDS) and WHO (WHO)

Simian immunodeficiency virus infection in wild-caught chimpanzees from cameroon

Origins of HIV and the AIDS pandemic. Cold Spring HarbPerspectMed

Analysis of the evolutionary relationships of HIV-1 and SIVcpz sequences using bayesian inference: implications for the origin of HIV-1

Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two cocirculating SIVmus lineages. Virology

Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon

Hybrid origin of SIV in chimpanzees. Science (80-)

Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. EBioMedicine

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates

Is HIV-1 evolving to a less virulent form in humans?

Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort

Subtypes of human immunodeficiency virus type 1 and disease stage among women in

CCR5-and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic

Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina

A dual infection/competition assay shows a correlation between Ex vivo human immunodeficiency virus type 1 fitness and disease progression

Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression

Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys

Simian Immunodeficiency Virus SIVagm Dynamics in African Green Monkeys

Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees

What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? AIDS Rev

Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz

HIV interaction with human host: HIV-2 As a model of a less virulent infection

HIV-2-infected patients survive longer than HlV-1-infected patients

Human Immunodeficiency Virus Type 1 Induces Apoptosis in CD4+ but Not in CD8+ T Cells in Ex Vivo-Infected Human Lymphoid Tissue

Biological Signature Characteristics of Primary Isolates from Human Immunodeficiency Virus Type 1 Group O in Ex Vivo Human Tonsil Histocultures

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates

Sorting out the complexities of HIV-1 fitness [2]

Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C

In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms

Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination

Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina

Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: Impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors

SeekDeep: Single-base resolution de novo clustering for amplicon deep sequencing

HIV-1 group O origin, evolution, pathogenesis, and treatment: Unraveling the complexity of an outlier 25 years later

HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med

HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues

A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution

Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2

The molecular population genetics of HIV-1 group O

Timing the ancestor of the HIV-1 pandemic strains

Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time

In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytiuminducing variants and correlates with the rate of CD4(+) T cell decline

Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates

Dendritic Cells Enhance HIV Infection of Memory CD4(+) T Cells in Human Lymphoid Tissues

Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr-and nef-negative derivatives

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

MEGA2: molecular evolutionary genetics analysis software

Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replication

Competing interests: None of the authors have competing financial interest related to this study.1way ANOVA (using data of Figure 4A ) 1way ANOVA (using data of Figure 4B ) 1way ANOVA (using data of Figure 4C ) 1way ANOVA (using data of Figure 4D ) 1way ANOVA (using data of Figure 5A ) 1way ANOVA (using data of Figure 5B )